Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Journal of the National Cancer Institute|February 5, 2019
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation TherapyMaria B Koenigs, Armida Lefranc-Torres, Juliana Bonilla-Velez, et al.
Nature Communications|March 16, 2022
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genesIndu Kohaar, Xijun Zhang, Shyh-Han Tan, et al.
Science Advances|December 22, 2023
Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancerMehdi Chaib, Jeremiah R Holt, Emilie L Fisher, et al.
Oncogene|June 2, 2025
An FGFR-p53 developmental signaling axis drives salivary cancer progressionAdele M Musicant, Julia M R Billington, Jeffrey S Damrauer, et al.
NPJ Breast Cancer|July 20, 2017
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome AtlasMelissa A Troester, Katherine A Hoadley, Monica D'Arcy, et al.
The Journal of Clinical Investigation|August 8, 2009
HIF2alpha cooperates with RAS to promote lung tumorigenesis in miceWilliam Y Kim, Samanthi Perera, Bing Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2024
A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticitySarah Asemota, Wendy Effah, Jeremiah Holt, et al.
Advances in Radiation Oncology|November 24, 2022
Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234Chieko Michikawa, Pedro A Torres-Saavedra, Natalie L Silver, et al.
Cancer Research|March 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor MicroenvironmentSofia Ferreira, Brittany M Flowers, Won-Young Choi, et al.
Cancer Research Communications|March 6, 2026
The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer - results from the NRG/RTOG 1016 trialJoanne B Weidhaas, Jonathan Harris, Maura L Gillison, et al.
Pageof 23